Valuation: Zai Lab Limited

Market Cap 2.7B 2.41B 2.23B 2.02B 3.77B 256B 3.84B 26.78B 10.6B 134B 10.12B 9.91B 423B P/E 2026 *
-10.9x
P/E 2027 * -10.9x
Enterprise Value 2.24B 2B 1.85B 1.67B 3.13B 213B 3.18B 22.24B 8.8B 111B 8.41B 8.23B 351B EV / Sales 2026 *
5.13x
EV / Sales 2027 * 4.2x
Free-Float
94.05%
Yield 2026 *
-
Yield 2027 * -

Last Transcript: Zai Lab Limited

1 day+9.03%
1 week+3.62%
Current month-8.77%
1 month-9.11%
3 months+22.10%
6 months+9.83%
Current year+36.22%
1 week 21.6
Extreme 21.6
25.5
1 month 21.6
Extreme 21.6
26.92
Current year 15.96
Extreme 15.96
27.5
1 year 15.96
Extreme 15.96
27.5
3 years 13.48
Extreme 13.48
44.34
5 years 13.48
Extreme 13.48
105.85
10 years 13.48
Extreme 13.48
193.54
Manager TitleAgeSince
Chief Executive Officer 61 2014-03-31
Director of Finance/CFO 58 2023-07-06
President 62 2022-11-30
Director TitleAgeSince
Chairman 61 2014-03-31
Director/Board Member 83 2016-12-31
Director/Board Member 75 2016-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
10/1/26 Exercice

Chief Financial Officer

2,155 0.0002%
8/19/26 Sell

Chief Financial Officer

-260 0.0000%
8/14/26 Exercice

Chief Financial Officer

2,927 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+9.03%+3.62%-14.24%-0.04% 2.7B
-2.54%+1.31%+55.10%+120.84% 1,135B
-1.42%+3.23%+37.07%+74.26% 636B
+0.16%+0.08%+25.14%+97.36% 505B
-0.31%+3.09%+43.92%+64.55% 378B
-1.34%-0.47%+66.63%+40.56% 358B
-0.68%+2.65%+22.46%+51.48% 295B
-1.20%+3.04%+2.62%+26.97% 266B
-1.79%+1.57%+49.97%+60.87% 237B
-0.73%-0.10%+29.24%+101.19% 193B
Average +0.30%+2.31%+31.79%+63.80% 400.7B
Weighted average by Cap. -0.25%+2.66%+40.96%+82.07%

Financials

2026 *2027 *
Net sales 436M 390M 360M 326M 610M 41.43B 621M 4.33B 1.72B 21.71B 1.64B 1.6B 68.44B 552M 493M 455M 413M 772M 52.41B 785M 5.48B 2.17B 27.46B 2.07B 2.03B 86.58B
Net income -241M -215M -199M -180M -337M -22.85B -342M -2.39B -946M -11.97B -903M -884M -37.74B -211M -188M -174M -158M -295M -20.04B -300M -2.1B -830M -10.5B -792M -775M -33.1B
Net Debt -458M -409M -378M -342M -640M -43.44B -651M -4.54B -1.8B -22.76B -1.72B -1.68B -71.76B -381M -340M -314M -285M -533M -36.15B -541M -3.78B -1.5B -18.94B -1.43B -1.4B -59.71B
Projected Income Statement - Annual - Zai Lab Limited
Logo Zai Lab Limited
Zai Lab Ltd is a holding company primarily engaged in biopharmaceutical business. The Company is focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. The Company has a series of patented drug candidates from the discovery stage to the late clinical project, including ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others. The Company conducts its businesses within domestic and overseas markets.
Employees
1,784
Date Price Change Volume
26-10-23 $24.03 +9.03% 3,691,476
26-10-22 $22.04 -8.93% 1,438,905
26-10-21 $24.20 -3.51% 1,197,868
26-10-20 $25.08 +4.24% 805,469
26-10-19 $24.06 +3.75% 383,625
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
MarketScreener Ratings - Zai Lab Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
24.03USD
Average target price
33.14USD
Spread / Average Target
+37.91%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Zai Lab Limited
  1. Stock Market
  2. Stocks
  3. ZLAB Stock